Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Profit After Tax: 2011-2024

Historic Profit After Tax for Agios Pharmaceuticals (AGIO) over the last 14 years, with Dec 2024 value amounting to $673.7 million.

  • Agios Pharmaceuticals' Profit After Tax fell 110.91% to -$103.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$401.3 million, marking a year-over-year decrease of 159.51%. This contributed to the annual value of $673.7 million for FY2024, which is 291.35% up from last year.
  • According to the latest figures from FY2024, Agios Pharmaceuticals' Profit After Tax is $673.7 million, which was up 291.35% from -$352.1 million recorded in FY2023.
  • Agios Pharmaceuticals' Profit After Tax's 5-year high stood at $1.6 billion during FY2021, with a 5-year trough of -$352.1 million in FY2023.
  • Its 3-year average for Profit After Tax is $29.9 million, with a median of -$231.8 million in 2022.
  • Per our database at Business Quant, Agios Pharmaceuticals' Profit After Tax skyrocketed by 587.30% in 2021 and then slumped by 114.44% in 2022.
  • Agios Pharmaceuticals' Profit After Tax (Yearly) stood at -$329.3 million in 2020, then soared by 587.30% to $1.6 billion in 2021, then slumped by 114.44% to -$231.8 million in 2022, then crashed by 51.89% to -$352.1 million in 2023, then skyrocketed by 291.35% to $673.7 million in 2024.